We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 90 start-ups with an aggregate funding of $2.6b. The average funding per company in this subset is $37.9m.
Last update to the database: Feb 18, 2025. See changelog.
15
Funding Rounds
$140.4m
Money raised
Synthace is a software company based out of London, UK, building automation software that gives biologists the ability to control and analyze the performance of lab hardware.
2
Funding Rounds
$16.8m
Money raised
Orbit Discovery offers a DNA-encoded peptide display technology to identify potential peptide drugs for a range of chronic diseases.
6
Funding Rounds
$190.5m
Money raised
Kuur Therapeutics focuses on the development of CAR-NKT cell therapies platform for applications in cancer treatment.
3
Funding Rounds
$143.4m
Money raised
An exosome therapeutics company founded in 2016 and based in Oxford, UK, that uses exosomes to deliver small and large molecule therapeutics. The company has a proprietary technology to modify exosomes to target specific organs such as the brain and central nervous system.
2
Funding Rounds
$11.3m
Money raised
Emergex aims to tackle the global threat of infectious disease by providing affordable and practical on-demand vaccine solutions.
7
Funding Rounds
$31.4m
Money raised
Oxford Genetics, also known as Oxgene, is a synthetic biology company specializing in DNA design, protein expression optimization and cell line development technologies and services.
1
Funding Rounds
$100.0m
Money raised
A biotechnology company using mass spectrometry platforms for drug discovery and the development of therapeutics.
2
Funding Rounds
$37.5m
Money raised
A biomedical company in United Kingdom that develops vaccines and vaccine development technology
2
Funding Rounds
$40.0m
Money raised
54Gene is healthcare startup company providing a genetics testing platform in Africa. It also offers genetic reports on health, nutrition, fitness and weight loss, carrier status, personal traits and ancestry.
11
Funding Rounds
$35.7m
Money raised
Lightpoint Medical is a solutions developer and provider for the health care industry, specializing in the development of intra-operative, robot-guided systems.
1
Funding Rounds
$4.7m
Money raised
Asimov is a startup that programs living cells with genetic circuits.
1
Funding Rounds
$3.9m
Money raised
Company developing rapid diagnostic technologies, products and services in human healthcare, agriculture and aquaculture
1
Funding Rounds
Isomerase is a Cambridge based microbial natural products drug discovery and development CRO and synthetic biology, fermentation and chemistry service provider
3
Funding Rounds
$13.2m
Money raised
Biosceptre is a Cambridge, Cambridgeshire-based company developing diagnostic tools and biomarkers.
2
Funding Rounds
$10.0m
Money raised
Macomics is an Edinburgh-based immuno-oncology company.
4
Funding Rounds
$179.4m
Money raised
Kymab is a biopharmecutical company developing human antibody based therapies founded in 2010.
1
Funding Rounds
Oxford Cancer Biomarkers is an Oxford-based biomarker company commercializing biomarker tests for colorectal cancer testing.
1
Funding Rounds
$125.0m
Money raised
Touchlight is a London-based biotechnology company founded in 2008 which focuses on DNA technology.
1
Funding Rounds
$12.7m
Money raised
The company aims to restore autophagy to boost cell rejuvenation and treat currently incurable neurodegenerative and rare genetic diseases.
7
Funding Rounds
$25.9m
Money raised
Oxford BioTherapeutics is a clinical-stage oncology company based in Oxford, UK, Morristown, and San Jose, USA. The company develops immuno-oncology (IO) and antibody-drug conjugate (ADC) based therapies.
6
Funding Rounds
$203.4m
Money raised
Binx Health Limited is a developer of point-of-care testing platforms.
2
Funding Rounds
$33.3m
Money raised
Developer of immunotherapy for the treatment of infectious diseases.
2
Funding Rounds
$6.4m
Money raised
Laboratory robotics and automation company
5
Funding Rounds
$162.0m
Money raised
A clinical cancer genomics company using liquid biopsy in cancer patients
5
Funding Rounds
$65.8m
Money raised
Theolytics Ltd is an oncolytic Adenovirus Therapies founded in 2017.
7
Funding Rounds
$14.1m
Money raised
Cytox Limited is a company founded in 2004 by Zsuzsanna Nagy.
3
Funding Rounds
$10.9m
Money raised
Medical device compnay focused on improving outcomes for mothers and babies during childbirth and delivery.
5
Funding Rounds
$146.6m
Money raised
Oxford Immunotec is a Marlborough, Massachusetts-based medical diagnostics company manufacturing tests for various diseases based on T cell measurement technology.
1
Funding Rounds
$25.0m
Money raised
Mevion Medical Systems is a company developing radiation therapies for cancer treatment founded in 2004 by Tina Tianning Yu.
1
Funding Rounds
Sygnature Discovery Limited is a drug Discovery Contract Research founded in 2004 by Simon Hirst.
2
Funding Rounds
$5.4m
Money raised
Kinomica is a Cheshire, United Kingdom-based proteomic-data science and diagnostics company that specializes in cell-signaling.
1
Funding Rounds
A pharmaceutical company specializing in drug candidates used for in out-patient and hospital-based sedation
1
Funding Rounds
$718.0k
Money raised
A company offering medicinal chemistry and computational chemistry services for drug dicovery
4
Funding Rounds
SiSaf is the first company to create a Bio-Courier platform technology.
4
Funding Rounds
$34.9m
Money raised
Sense Biodetection Limited is an Abingdon-on-Thames-based molecular diagnostics company developing handheld tests in the fields of infections and oncology.
3
Funding Rounds
$70.0m
Money raised
Biofidelity Ltd is a genetic Testing Technology founded in 2019 by Barnaby Balmforth.
1
Funding Rounds
$13.0m
Money raised
Chronos is an Oxford-based biotechnology company operating a semi-virtual R&D model to develop a portfolio of therapies in degenerative and behavioral brain diseases.
1
Funding Rounds
$1.2m
Money raised
ValiRx PLC. is a Cambridge, Massachusetts-based healthcare accelerator working to develop new medicines and technologies founded in 2000.
1
Funding Rounds
$36.0m
Money raised
Perspectum Diagnostics Ltd is an Oxford-based developer of diagnostic technologies for diagnosing patients with liver disease, diabetes, and cancer.
2
Funding Rounds
Akrivis Technologies is a Cambridge, Massachusetts-based medical diagnostics company developing solutions for infectious diseases founded in 2009 by Dr. Ban–An Khaw.
1
Funding Rounds
Oncimmune is a Nottingham-based diagnostic company developing early cancer detection products.
7
Funding Rounds
$74.7m
Money raised
Mobidiag UK Ltd is an Espoo-based molecular diagnostic company developing solutions for the detection of infectious diseases.
2
Funding Rounds
$34.5m
Money raised
DYSIS Medical is focused on developing imaging systems for the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions.
1
Funding Rounds
$23.5m
Money raised
Blue Earth Diagnostics Limited is an Oxford-based developer and supplier of molecular imaging agents.
1
Funding Rounds
$29.0m
Money raised
Renalytix is a developer of artificial intelligence (AI) enabled clinical diagnostic solutions for kidney disease.
1
Funding Rounds
$2.2m
Money raised
Aptamer Group Limited is a York-based developer of nucleic acid aptamers for use in research and development, biomarker discovery, diagnostics and therapeutic applications.
2
Funding Rounds
$3.0m
Money raised
Mgb Biopharma is a biopharmaceutical company developing anti-infective medicines founded in 2010.
1
Funding Rounds
$8.0m
Money raised
Treos Bio is a cancer Vaccine Technology founded in 2013 by John Hautman.
1
Funding Rounds
Enesi Pharma Limited is a solid Dose Vaccine Delivery founded in 2017.
2
Funding Rounds
$2.9m
Money raised
Gentronix is a biotechnology company developing predictive toxicology technologies.
2
Funding Rounds
$40.4m
Money raised
Wren Therapeutics is a small Molecules Targeting Protein Mis-Folding founded in 2016 by Chris Dobson.
1
Funding Rounds
$675.0k
Money raised
Mendelian Ltd is a London-based diagnostics company developing rare disease diagnostics.
2
Funding Rounds
$12.6m
Money raised
Oxford Vacmedix UK Limited is a cancer Vaccines founded in 2012 by Dr Shisong Jiang.
2
Funding Rounds
$1.3m
Money raised
Small Pharma is a London-based pharmaceutical company researching applications of DMT and ketamine in psychedelic-assisted psychotherapy to help treat conditions like clinical depression.
1
Funding Rounds
$8.0m
Money raised
Adaptix is an Oxford-based company developing radiology technologies.
3
Funding Rounds
$3.6m
Money raised
Momentum Bioscience is a Cardiff-based medical diagnostics company developing blood-based molecular diagnostics.
2
Funding Rounds
$1.7m
Money raised
nanoTherics is a transfection Technology founded by Jon Dobson.
2
Funding Rounds
$4.6m
Money raised
Scancell is a cancer vaccine founded in 1996 by Professor Lindy Durrant.
1
Funding Rounds
EKF Diagnostics is a Cardiff-based medical diagnostics company developing point-of-care and laboratory devices and reagents.
1
Funding Rounds
$3.1m
Money raised
Altacor is an ophthalmic Specialty Pharmaceuticals founded in 2007.
2
Funding Rounds
$29.5m
Money raised
ONK Therapeutics is a natural Killer Cell Therapies founded in 2015.
5
Funding Rounds
$17.2m
Money raised
QuantuMDx Group is a Newcastle Higher-based medical device company designing and manufacturing devices for molecular diagnostics.
1
Funding Rounds
$50.0m
Money raised
Transition Bio is a condensate technology, liquid-liquid phase separation founded by Peter St George-Hyslop.
1
Funding Rounds
OSSIANIX is a biotherapeutics company developing single domain antibodies founded by Frank S. Walsh.
2
Funding Rounds
$157.5m
Money raised
Peptide Conjugation Technology for Gene Delivery
1
Funding Rounds
$47.0m
Money raised
ADCs
1
Funding Rounds
$41.0m
Money raised
Enterprise Therapeutics is a respiratory Treatments founded in 2014.
1
Funding Rounds
$10.0m
Money raised
Carterra is a provider of high-throughput technologies designed for the discovery of novel therapeutic candidates.
3
Funding Rounds
$56.6m
Money raised
NeRRe Therapeutics is a small Molecules founded in 2012.
Enter your email and get access to 71,000 + technology companies you can partner with.